Annual Working Capital
$4.67 M
-$2.65 M-36.20%
December 31, 2023
Summary
- As of February 7, 2025, ACXP annual working capital is $4.67 million, with the most recent change of -$2.65 million (-36.20%) on December 31, 2023.
- During the last 3 years, ACXP annual working capital has risen by +$1.92 million (+69.61%).
- ACXP annual working capital is now -62.40% below its all-time high of $12.41 million, reached on December 31, 2021.
Performance
ACXP Working Capital Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Highlights
High & Low
Earnings dates
Quarterly Working Capital
$2.66 M
-$763.50 K-22.28%
September 30, 2024
Summary
- As of February 7, 2025, ACXP quarterly working capital is $2.66 million, with the most recent change of -$763.50 thousand (-22.28%) on September 30, 2024.
- Over the past year, ACXP quarterly working capital has dropped by -$1.27 million (-32.29%).
- ACXP quarterly working capital is now -82.84% below its all-time high of $15.52 million, reached on June 30, 2021.
Performance
ACXP Quarterly Working Capital Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Highlights
High & Low
Earnings dates
Working Capital Formula
Working Capital = Current Assets − Current Liabilities
ACXP Working Capital Trends
| PeriodPeriod | AnnualAnnual | QuarterlyQuarterly |
|---|---|---|
| 1 y1 year | -36.2% | -32.3% |
| 3 y3 years | +69.6% | -57.1% |
| 5 y5 years | +469.3% | -57.1% |
ACXP Working Capital Highs & Lows
| PeriodPeriod | Annual vs highAnnual vs high | Annual vs lowAnnual vs low | Quarter. vs highQuarter. vs high | Quarter. vs lowQuarter. vs low | |
|---|---|---|---|---|---|
| 3 y | 3-year | -62.4% | at low | -78.5% | at low |
| 5 y | 5-year | -62.4% | +469.3% | -82.8% | +22.1% |
| alltime | all time | -62.4% | +469.3% | -82.8% | +22.1% |
Acurx Pharmaceuticals Working Capital History
| Date | Annual | Quarterly |
|---|---|---|
| Sep 2024 | - | $2.66 M(-22.3%) |
| Jun 2024 | - | $3.43 M(-42.9%) |
| Mar 2024 | - | $6.00 M(+28.5%) |
| Dec 2023 | $4.67 M(-36.2%) | $4.67 M(+18.6%) |
| Sep 2023 | - | $3.93 M(-36.7%) |
| Jun 2023 | - | $6.22 M(+17.0%) |
| Mar 2023 | - | $5.31 M(-27.4%) |
| Dec 2022 | $7.32 M | $7.32 M(-25.1%) |
| Date | Annual | Quarterly |
|---|---|---|
| Sep 2022 | - | $9.76 M(+11.8%) |
| Jun 2022 | - | $8.74 M(-18.3%) |
| Mar 2022 | - | $10.69 M(-13.9%) |
| Dec 2021 | $12.41 M(+351.1%) | $12.41 M(-13.1%) |
| Sep 2021 | - | $14.28 M(-8.0%) |
| Jun 2021 | - | $15.52 M(+611.5%) |
| Mar 2021 | - | $2.18 M(-20.7%) |
| Dec 2020 | $2.75 M(+235.6%) | $2.75 M |
| Dec 2019 | $819.80 K | - |
FAQ
- What is Acurx Pharmaceuticals annual working capital?
- What is the all time high annual working capital for Acurx Pharmaceuticals?
- What is Acurx Pharmaceuticals annual working capital year-on-year change?
- What is Acurx Pharmaceuticals quarterly working capital?
- What is the all time high quarterly working capital for Acurx Pharmaceuticals?
- What is Acurx Pharmaceuticals quarterly working capital year-on-year change?
What is Acurx Pharmaceuticals annual working capital?
The current annual working capital of ACXP is $4.67 M
What is the all time high annual working capital for Acurx Pharmaceuticals?
Acurx Pharmaceuticals all-time high annual working capital is $12.41 M
What is Acurx Pharmaceuticals annual working capital year-on-year change?
Over the past year, ACXP annual working capital has changed by -$2.65 M (-36.20%)
What is Acurx Pharmaceuticals quarterly working capital?
The current quarterly working capital of ACXP is $2.66 M
What is the all time high quarterly working capital for Acurx Pharmaceuticals?
Acurx Pharmaceuticals all-time high quarterly working capital is $15.52 M
What is Acurx Pharmaceuticals quarterly working capital year-on-year change?
Over the past year, ACXP quarterly working capital has changed by -$1.27 M (-32.29%)